455 related articles for article (PubMed ID: 21167141)
41. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
Lü JM; Yao Q; Chen C
Biochem Pharmacol; 2013 Nov; 86(9):1328-37. PubMed ID: 23994369
[TBL] [Abstract][Full Text] [Related]
42. Lithospermic acid as a novel xanthine oxidase inhibitor has anti-inflammatory and hypouricemic effects in rats.
Liu X; Chen R; Shang Y; Jiao B; Huang C
Chem Biol Interact; 2008 Nov; 176(2-3):137-42. PubMed ID: 18694741
[TBL] [Abstract][Full Text] [Related]
43. Antioxidant, antihyperuricemic and xanthine oxidase inhibitory activities of Hyoscyamus reticulatus.
Mohammad MK; Almasri IM; Tawaha K; Issa A; Al-Nadaf A; Hudaib M; Alkhatib HS; Abu-Gharbieh E; Bustanji Y
Pharm Biol; 2010 Dec; 48(12):1376-83. PubMed ID: 20738177
[TBL] [Abstract][Full Text] [Related]
44. Effects of genistein, apigenin, quercetin, rutin and astilbin on serum uric acid levels and xanthine oxidase activities in normal and hyperuricemic mice.
Huang J; Wang S; Zhu M; Chen J; Zhu X
Food Chem Toxicol; 2011 Sep; 49(9):1943-7. PubMed ID: 21600261
[TBL] [Abstract][Full Text] [Related]
45. In vitro Xanthine Oxidase Inhibitory Studies of Lippia nodiflora and Isolated Flavonoids and Phenylethanoid Glycosides as Potential Uric Acid-lowering Agents.
Cheng LC; Murugaiyah V; Chan KL
Nat Prod Commun; 2015 Jun; 10(6):945-8. PubMed ID: 26197523
[TBL] [Abstract][Full Text] [Related]
46. Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
Zhu JX; Wang Y; Kong LD; Yang C; Zhang X
J Ethnopharmacol; 2004 Jul; 93(1):133-40. PubMed ID: 15182918
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site.
Sun M; Zhao J; Mao Q; Yan C; Zhang B; Yang Y; Dai X; Gao J; Lin F; Duan Y; Zhang T; Wang S
Bioorg Med Chem; 2021 May; 38():116117. PubMed ID: 33838610
[TBL] [Abstract][Full Text] [Related]
48. X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin.
Cao H; Pauff JM; Hille R
J Nat Prod; 2014 Jul; 77(7):1693-9. PubMed ID: 25060641
[TBL] [Abstract][Full Text] [Related]
49. Schiff base transition metal complexes as novel inhibitors of xanthine oxidase.
You ZL; Shi DH; Xu C; Zhang Q; Zhu HL
Eur J Med Chem; 2008 Apr; 43(4):862-71. PubMed ID: 17706325
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics/pharmacodynamics of Y-700, a novel xanthine oxidase inhibitor, in rats and man.
Yamada I; Fukunari A; Osajima T; Kamezawa M; Mori H; Iwane J
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1123-5. PubMed ID: 15571214
[TBL] [Abstract][Full Text] [Related]
51. Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.
Ao GZ; Zhou MZ; Li YY; Li SN; Wang HN; Wan QW; Li HQ; Hu QH
Bioorg Med Chem; 2017 Jan; 25(1):166-174. PubMed ID: 28340987
[TBL] [Abstract][Full Text] [Related]
52. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K
Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors.
Sun ZG; Zhou XJ; Zhu ML; Ding WZ; Li Z; Zhu HL
Chem Pharm Bull (Tokyo); 2015; 63(8):603-7. PubMed ID: 26040271
[TBL] [Abstract][Full Text] [Related]
54. Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L.) Pers.
Unno T; Sugimoto A; Kakuda T
J Ethnopharmacol; 2004 Aug; 93(2-3):391-5. PubMed ID: 15234783
[TBL] [Abstract][Full Text] [Related]
55. Benzophenones as xanthine oxidase inhibitors.
Sheu SY; Tsai HJ; Chiang HC
Anticancer Res; 1999; 19(2A):1131-5. PubMed ID: 10368664
[TBL] [Abstract][Full Text] [Related]
56. Effect of luteolin on xanthine oxidase: inhibition kinetics and interaction mechanism merging with docking simulation.
Yan J; Zhang G; Hu Y; Ma Y
Food Chem; 2013 Dec; 141(4):3766-73. PubMed ID: 23993547
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of some 5-phenylisoxazole-3-carboxylic acid derivatives as potent xanthine oxidase inhibitors.
Wang S; Yan J; Wang J; Chen J; Zhang T; Zhao Y; Xue M
Eur J Med Chem; 2010 Jun; 45(6):2663-70. PubMed ID: 20189693
[TBL] [Abstract][Full Text] [Related]
58. Effects of lobetyolin on xanthine oxidase activity
Yoon IS; Cho SS
Nat Prod Res; 2021 May; 35(10):1667-1670. PubMed ID: 31140315
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors.
Singh H; Sharma S; Ojha R; Gupta MK; Nepali K; Bedi PM
Bioorg Med Chem Lett; 2014 Sep; 24(17):4192-7. PubMed ID: 25106887
[TBL] [Abstract][Full Text] [Related]
60. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
